It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or
consider using other browsers such as Chrome, Firefox or Safari.
As the healthcare and insurance industries evolve, we know that getting patients started on treatment can be complicated. Our dedicated OmniSource® team is here to make this process as smooth as possible and help your patients get started on treatment without delay.
If there are delays in the insurance process, eligible patients may receive their medication and injection device within 10 business days of qualifying for SOS, so they don’t have to delay their treatment while waiting for insurance approvals.
SOS can cover patients for up to 1 full year of interim treatment assistance.†
Questions? Call us: 877.456.6794 (Monday – Friday, 8 AM – 8 PM ET).
1. Omnitrope [package insert]. Princeton, NJ: Sandoz Inc; 2019.
Savings support for the journey ahead - eligible patients may pay as little as $0 for their Co-Pay.*
The OmniSource Team provides personalized support services to help your patients each step of the way.
We’re committed to serving a wide variety of patients prescribed growth hormone.
Personalized support, each step of the way. Click here to enroll your patient.
Omnitrope® is a recombinant human growth hormone indicated for:
Please see full Prescribing Information for Omnitrope.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch